Cognitive

Overview

Cognitive peptide research examines neuropeptides and neurotrophic peptide mixtures studied for memory, attention, mood, and neuroprotection. The flagship investigational agent is Cerebrolysin, a porcine-brain-derived peptide preparation with decades of European clinical use in stroke and dementia. Selank and Semax are short Russian-developed regulatory peptides studied for anxiolytic and nootropic effects. Other compounds in this category include DSIP (delta sleep-inducing peptide) for sleep-cognition interactions, Pinealon for neuroprotection in oxidative-stress models, and VIP for cholinergic and inflammatory modulation in the CNS. Most cognitive peptide evidence is preclinical or single-center clinical work outside North America.